Skip to main content

LCD L34171: Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation

LCD L34171, Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation, is the Local Coverage Determination that CGS Administrators, LLC applies to claims from 2 states (KY, OH), effective 2026-05-28 and first in force 2015-10-01. The policy text runs 744 words, and its billing and coding article A57284 lists 30 ICD-10-CM codes that support medical necessity for 6 procedure codes. No other contractor publishes a policy with this title.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Contractor
CGS Administrators, LLC
States and territories
2
KY OH
Revision effective
2026-05-28
Original effective
2015-10-01
Policy text
744 words
Covered ICD-10 codes (articles)
30

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L34171
ContractContractorTypeStates
15102CGS Administrators, LLCMAC - Part BKY
15202CGS Administrators, LLCMAC - Part BOH
15101CGS Administrators, LLCMAC - Part AKY
15201CGS Administrators, LLCMAC - Part AOH

Billing and coding article A57284: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57284 (Billing and Coding: Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.

Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.

A57284: Billing and Coding: Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation (Billing and Coding, effective 2026-05-28)

Covered ICD-10-CM codes
30
1 group
Non-covered ICD-10-CM codes
3
Procedure codes listed
6
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57284
ICD-10-CMDescription (FY2027)
H04.201Unspecified epiphora, right side
H04.202Unspecified epiphora, left side
H04.203Unspecified epiphora, bilateral
H04.221Epiphora due to insufficient drainage, right side
H04.222Epiphora due to insufficient drainage, left side
H04.223Epiphora due to insufficient drainage, bilateral
H04.411Chronic dacryocystitis of right lacrimal passage
H04.412Chronic dacryocystitis of left lacrimal passage
H04.413Chronic dacryocystitis of bilateral lacrimal passages
H04.431Chronic lacrimal mucocele of right lacrimal passage
H04.432Chronic lacrimal mucocele of left lacrimal passage
H04.433Chronic lacrimal mucocele of bilateral lacrimal passages
H04.541Stenosis of right lacrimal canaliculi
H04.542Stenosis of left lacrimal canaliculi
H04.543Stenosis of bilateral lacrimal canaliculi
H04.551Acquired stenosis of right nasolacrimal duct
H04.552Acquired stenosis of left nasolacrimal duct
H04.553Acquired stenosis of bilateral nasolacrimal duct
H04.561Stenosis of right lacrimal punctum
H04.562Stenosis of left lacrimal punctum
H04.563Stenosis of bilateral lacrimal punctum
H10.401Unspecified chronic conjunctivitis, right eye
H10.402Unspecified chronic conjunctivitis, left eye
H10.403Unspecified chronic conjunctivitis, bilateral

Procedure codes: 68801, 68810, 68811, 68815, 68816, 68840.

Coverage indications, limitations and medical necessity

Abstract:

Dilation of nasolacrimal punctum and probing of nasolacrimal duct, with or without irrigation are useful treatments when mechanical, inflammatory or infectious processes cause or contribute to obstruction of normal tear drainage resulting in epiphora (excess tearing) or persistent infection.

The most common cause of obstruction in adults is primary acquired nasolacrimal duct obstruction (PANDO). Epiphora (excess tearing) is the most common symptom of obstruction of the nasolacrimal system. Tear duct obstruction in adults can occur at any point in the nasolacrimal system including the punctum, nasolacrimal sac, and nasolacrimal duct. Obstruction most commonly occurs in the puncta or nasolacrimal duct and sac. Disease of the canalicular system is less common.

It is important to differentiate between chronic epiphora, acute epiphora, and normal tearing. Chronic epiphora results from a persistent or continuous disorder and usually presents a more challenging clinical problem. Acute epiphora usually results from irritative ocular conditions such as corneal foreign bodies, allergic conjunctivitis, environmental factors such as wind, pollen, eyestrain, emotional stress, and sleep deprivation. One of the most common causes of excess tearing in older adults is dry eye syndrome. Acute epiphora usually resolves with treatment of the associated disorder and may not require dilation or probing.

Before dilation and/or probing are performed, pre-punctal disturbances of ocular surface tear flow such as lid malposition and non-obstructive causes (allergy, dry eye, blepharitis, etc.) should be excluded. Tear production measurement (Schirmer test), and tear break-up time (TBUT) can indicate insufficiency or instability of tears, which can cause or contribute to epiphora. Dye disappearance testing (sodium fluorescein), Jones dye testing or saccharine testing can be used to exclude significant obstruction and/or help identify the site and degree of obstruction.

If after the history, physical examination (including slit lamp), and other appropriate non-invasive tests have been completed, the site of obstruction is suspected to be at or distal to the punctum, dilation may proceed. Local anesthetic is instilled, and then the punctum is gradually dilated using probes of increasing size. If simple dilation fails to establish patency, lacrimal probing may be performed by passing a malleable wire probe through the punctum, into the canaliculus, lacrimal sac and down the nasolacrimal duct until patency is established. Irrigation may be used during both dilation and probing.

For patients in whom nasolacrimal duct probing has failed, further surgical treatment is available.

Punctal dilation and lacrimal duct probing is contraindicated in the following circumstances:

• Anatomic malformations in the lacrimal duct or bony lacrimal canal;

• Recurrent episodes of active dacryocystitis;

• Post-traumatic strictures with bony narrowing;

• Tumor of the lacrimal sac.

For procedural illustration for probing of nasolacrimal duct, please refer to Current Procedural Terminology (CPT) 2021, pg 502.

Indications:

Nasolacrimal punctal dilation and nasolacrimal duct probing may be reasonable and necessary when obstruction at or distal to the lacrimal puncta is reasonably suspected to be causing or contributing to the patient's symptoms (usually excessive tearing (epiphora) or chronic dacryocystitis), and when such measures are required to alleviate the patient's symptoms and reduce the likelihood of infection or damage to the lacrimal drainage apparatus.

Probing of the nasolacrimal duct and/or dilation of the nasolacrimal punctum can be carried out for any of the following indications:

• Epiphora (excessive tearing) due to acquired obstruction within the nasolacrimal sac and duct;

• A mucocele of the lacrimal sac;

• Chronic dacryocystitis or conjunctivitis due to lacrimal sac obstruction;

• Lacrimal sac infection that must be relieved before intra-ocular surgery.

Limitations:

• Payment for these procedures for treatment of epiphora is limited to patients whose medical records indicate they have first undergone a thorough lacrimal evaluation that includes at least the following:

• Consideration by history and physical examination (including slit lamp), of likely pre-punctal and/or non-obstructive causes for epiphora such as disturbances of ocular surface tear flow by lid malposition, allergy, dry eye, blepharitis; and

• Non-invasive testing to diagnose punctal or post-punctal obstruction and to identify the site and degree of obstruction, such as by using dye disappearance testing when appropriate; followed by

• Initiation of appropriate treatment.

• Separate reimbursement for tear production measurement (Schirmer test), tear break-up time (TBUT), dye disappearance testing (sodium fluorescein), Jones dye testing or saccharine testing is not available. These are considered part of a general opthalmological examination or E&M service.

• Punctal dilation and lacrimal duct probing are not indicated for dacryocystolithiasis.

• Provision of any of these services is subject to state regulations, and individual providers’ scopes of practice.

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-05-28
Last reviewed by the contractor
2026-05-15
MCD version
18
Derived from
L31878

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the CGS Administrators, LLC hub lists every other active policy from the same contractor.

For teams evaluating QuickIntell software

Where QuickIntell fits with this policy

If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

What does LCD L34171 cover?

Dilation of nasolacrimal punctum and probing of nasolacrimal duct, with or without irrigation are useful treatments when mechanical, inflammatory or infectious processes cause or contribute to obstruction of normal tear drainage resulting in epiphora (excess tearing) or persistent infection. The full 744-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.

Which states does LCD L34171 apply to?

CGS Administrators, LLC applies it to Medicare claims in 2 states: KY, OH. It binds only that contractor; outside these jurisdictions the same service is judged under the local contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L34171?

The companion billing and coding article A57284 lists 30 ICD-10-CM codes in 1 group that support medical necessity and 3 that do not; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.

How do I appeal a denial under LCD L34171?

A denial under LCD L34171 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A57284's 30 covered diagnosis codes, then file a redetermination with CGS Administrators, LLC within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.